WhiteOak Capital Pharma and Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

WhiteOak Capital Pharma and Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹500

AUM (Fund size)

₹964 Cr

Lock In Period

N/A

Expense Ratio

2.72

Exit Load

Nil

Benchmark

BSE Healthcare Total Return

WhiteOak Capital Pharma and Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M11.210.5412.37
6M15.562.4919.07
1Y24.053.6133.09
3Y0.0012.46123.01

Portfolio Analysis

  • Equity: 90.63%
  • Debt: 4.06%
  • Others
As on: 2026-10-31
View allocation % by

1. Divi's Laboratories Limited8.87%
2. Sun Pharmaceutical Industries Limited6.68%
3. Torrent Pharmaceuticals Limited5.87%
4. Laurus Labs Limited5.59%
5. Zydus Lifesciences Limited3.10%
6. Sai Life Sciences Limited3.02%
7. IPCA Laboratories Limited2.91%
8. Mankind Pharma Limited2.50%
9. Corona Remedies Limited2.30%
10. Aurobindo Pharma Limited2.21%
11. Acutaas Chemicals Limited2.14%
12. Cipla Limited2.13%
13. Ajanta Pharma Limited2.07%
14. Neuland Laboratories Limited1.93%
15. Piramal Pharma Limited1.77%
16. Onesource Specialty Pharma Limited1.53%
17. Procter & Gamble Health Limited1.26%
18. Anthem Biosciences Limited1.22%
19. Aarti Pharmalabs Limited1.06%
20. Gland Pharma Limited0.95%
21. Innova Captab Limited0.75%
22. Sudeep Pharma Limited0.72%
23. Senores Pharmaceuticals Limited0.71%
24. Supriya Lifescience Limited0.59%
25. Biocon Limited0.58%
26. Novartis India Limited0.45%
27. Zota Health Care Limited0.40%
28. Orchid Pharma Limited0.24%
29. Symbiotec Pharmalab Limited0.18%
30. Bharat Parenterals Limited0.11%

1. Apollo Hospitals Enterprise Limited3.73%
2. Krishna Institute Of Medical Sciences Limited2.05%
3. Dr. Lal Path Labs Limited1.97%
4. Global Health Limited1.90%
5. Narayana Hrudayalaya Limited1.87%
6. Vijaya Diagnostic Centre Limited1.69%
7. Max Healthcare Institute Limited1.26%
8. Fortis Healthcare Limited1.07%
9. Paras Healthcare Limited1.06%
10. Thyrocare Technologies Limited1.01%
11. Kovai Medical Center and Hospital Limited0.89%
12. Jupiter Life Line Hospitals Limited0.71%
13. Molbio Diagnostics Limited0.53%
14. Nephrocare Health Services Ltd0.51%
15. Manipal Health Enterprises Ltd0.47%

1. Shaily Engineering Plastics Limited1.72%

1. Navin Fluorine International Limited1.43%

1. Aether Industries Limited1.03%
2. Tatva Chintan Pharma Chem Limited0.37%
No Data Found
No Data Found

About Fund WhiteOak Capital Pharma and Healthcare Fund Growth

WhiteOak Capital Pharma and Healthcare Fund Growth managed by WhiteOak Capital Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹964 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.72. Under the expert guidance of Ramesh Mantri ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Ramesh Mantri

Mr. Ramesh Mantri holds MBA, CFA and CA. His prior assignments include White Oak Capital Management LLP, Ashoka Capital Advisers, Smith Management-Mumbai Office and CRISIL.

WhiteOak Capital Pharma and Healthcare Fund Growth FAQs

WhiteOak Capital Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of WhiteOak Capital Pharma and Healthcare Fund Growth is 2.72. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

WhiteOak Capital Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 11.21%
  • 6 Months : 15.56%
  • 1 Year : 24.05%
  • 3 Years : 0.00%
Returns of WhiteOak Capital Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ 17.579 as on Nov 20,2026. Since inception, the return has been 0.00%.

You can invest in WhiteOak Capital Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of WhiteOak Capital Pharma and Healthcare Fund Growth is ₹964 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in WhiteOak Capital Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
  • Daily Research Calls
  • ₹0 AMC for First Year
  • Dedicated RM Support
Open a Free Demat Account
+ Free 1st Year AMC